177 related articles for article (PubMed ID: 35409069)
1. ELK3 Controls Gastric Cancer Cell Migration and Invasion by Regulating ECM Remodeling-Related Genes.
Lee M; Cho HJ; Park KS; Jung HY
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409069
[TBL] [Abstract][Full Text] [Related]
2. ETS transcription factor ELK3 in human cancers: An emerging therapeutic target.
Al-Hawary SIS; Pallathadka H; Hjazi A; Zhumanov ZE; Alazbjee AAA; Imad S; Alsalamy A; Hussien BM; Jaafer NS; Mahmoudi R
Pathol Res Pract; 2023 Aug; 248():154728. PubMed ID: 37542863
[TBL] [Abstract][Full Text] [Related]
3. [Expression characteristics and functional analysis of ELK3 in gastric cancer].
Zhou L; Wu Y; Xin L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(9):1287-1295. PubMed ID: 34658341
[TBL] [Abstract][Full Text] [Related]
4. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
5. ELK3 Expression Correlates With Cell Migration, Invasion, and Membrane Type 1-Matrix Metalloproteinase Expression in MDA-MB-231 Breast Cancer Cells.
Heo SH; Lee JY; Yang KM; Park KS
Gene Expr; 2015; 16(4):197-203. PubMed ID: 26637400
[TBL] [Abstract][Full Text] [Related]
6. ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.
Jung HY; Lee DK; Lee M; Choi SH; Park JD; Ko ES; Lee J; Park KS; Jung HY
Oncoimmunology; 2023; 12(1):2190671. PubMed ID: 36950218
[TBL] [Abstract][Full Text] [Related]
7. High
Dazhi W; Zheng J; Chunling R
Future Med Chem; 2020 Dec; 12(24):2209-2224. PubMed ID: 33191789
[No Abstract] [Full Text] [Related]
8. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
9. ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs.
Kim KS; Park JI; Oh N; Cho HJ; Park JH; Park KS
Sci Rep; 2019 Jun; 9(1):8418. PubMed ID: 31182803
[TBL] [Abstract][Full Text] [Related]
10. ELK3-ID4 axis governs the metastatic features of triple negative breast cancer.
Choi JH; Park JD; Choi SH; Ko ES; Jang HJ; Park KS
Oncol Res; 2023; 32(1):127-138. PubMed ID: 38188675
[TBL] [Abstract][Full Text] [Related]
11. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
Lee CJ; Lee H; Kim SR; Nam SB; Lee GE; Yang KE; Lee GJ; Chun SH; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
Cell Death Dis; 2024 Apr; 15(4):274. PubMed ID: 38632244
[TBL] [Abstract][Full Text] [Related]
12. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
Xia XQ; Lu WL; Ye YY; Chen J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
[TBL] [Abstract][Full Text] [Related]
13. ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.
Park JD; Kim KS; Choi SH; Jo GH; Choi JH; Park SW; Ko ES; Lee M; Lee DK; Jang HJ; Hwang S; Jung HY; Park KS
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858708
[TBL] [Abstract][Full Text] [Related]
14. Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells.
Mao Y; Li W; Hua B; Gu X; Pan W; Chen Q; Xu B; Wang Z; Lu C
Biomed Res Int; 2020; 2020():2406159. PubMed ID: 32104682
[TBL] [Abstract][Full Text] [Related]
15. XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.
Semenchenko K; Wasylyk C; Cheung H; Tourrette Y; Maas P; Schalken JA; van der Pluijm G; Wasylyk B
PLoS One; 2016; 11(7):e0159531. PubMed ID: 27427904
[TBL] [Abstract][Full Text] [Related]
16. Construction of gastric cancer prognostic signature based on the E26 transcription factor and the identification of novel oncogene ELK3.
Liu C; Zhou L; Chen Z
Am J Cancer Res; 2024; 14(4):1831-1849. PubMed ID: 38726274
[TBL] [Abstract][Full Text] [Related]
17. Methyltransferase-like protein 11A promotes migration of cervical cancer cells via up-regulating ELK3.
Zhang J; Song H; Chen C; Chen L; Dai Y; Sun PH; Zou C; Wang X
Pharmacol Res; 2021 Oct; 172():105814. PubMed ID: 34450313
[TBL] [Abstract][Full Text] [Related]
18. ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.
Cho HJ; Oh N; Park JH; Kim KS; Kim HK; Lee E; Hwang S; Kim SJ; Park KS
Mol Cancer Res; 2019 Nov; 17(11):2257-2266. PubMed ID: 31511359
[TBL] [Abstract][Full Text] [Related]
19. ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP.
Heo SH; Cho JY
Int J Biol Sci; 2014; 10(4):438-47. PubMed ID: 24719561
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer.
Zhang T; Li X; He Y; Wang Y; Shen J; Wang S; You Q; Zhai J; Shen L
Gastric Cancer; 2022 Mar; 25(2):346-359. PubMed ID: 34724589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
